| scholarly article | Q13442814 |
| P50 | author | Kevin Phan | Q39187230 |
| P2093 | author name string | Xiaoxia Wang | |
| Jin-Haeng Chung | |||
| Masaru Katoh | |||
| Hong Qian | |||
| Yong Song | |||
| Ping Zhan | |||
| Tangfeng Lv | |||
| Jiajia Jin | |||
| Written on behalf of the AME Lung Cancer Collaborative Group | |||
| P2860 | cites work | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Q21195843 |
| Epidemiology of Lung Cancer | Q22306069 | ||
| Identification of c-MYC as a target of the APC pathway | Q24310637 | ||
| Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients | Q80243203 | ||
| Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer | Q81545770 | ||
| Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer | Q84602189 | ||
| Non-small cell lung cancer: current treatment and future advances | Q26740333 | ||
| Wnt Signaling in Cancer Stem Cell Biology | Q26746101 | ||
| Wnt signaling pathway in non-small cell lung cancer | Q26825936 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
| FGF receptors: cancer biology and therapeutics | Q28291186 | ||
| Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer | Q28396304 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| WNT signalling pathways as therapeutic targets in cancer | Q29615666 | ||
| Overexpression of Wnt5a promotes angiogenesis in NSCLC. | Q33791918 | ||
| RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. | Q34494714 | ||
| Wnt1 overexpression promotes tumour progression in non-small cell lung cancer | Q34827017 | ||
| Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway | Q35666419 | ||
| Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | Q35904534 | ||
| Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer | Q36042289 | ||
| Wnt signaling in lung cancer | Q36101348 | ||
| Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis | Q36241849 | ||
| Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. | Q36413067 | ||
| WNT signaling pathway and stem cell signaling network | Q36883377 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| ALKoma: a cancer subtype with a shared target | Q38011984 | ||
| Acquired resistance to TKIs in solid tumours: learning from lung cancer | Q38224967 | ||
| Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine. | Q38484053 | ||
| Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells | Q39751974 | ||
| Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression | Q40443907 | ||
| Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia | Q43708535 | ||
| Survivin and molecular pathogenesis of colorectal cancer. | Q53922433 | ||
| Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. | Q54340040 | ||
| Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. | Q54611531 | ||
| The correlation between the expression of Wnt1 and prognosis in resected non-small cell lung cancer | Q55425896 | ||
| P433 | issue | 4 | |
| P921 | main subject | meta-analysis | Q815382 |
| non-small-cell lung carcinoma | Q3658562 | ||
| P304 | page(s) | 436-442 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Translational lung cancer research | Q26842616 |
| P1476 | title | Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis | |
| P478 | volume | 5 |
| Q52782809 | Celecoxib-erlotinib combination treatment enhances radiosensitivity in A549 human lung cancer cell. |
| Q38696296 | EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line. |
| Q64076870 | MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1 |
| Q33831066 | PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway |
| Q36281362 | miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer |
Search more.